Doxorubicin and Ifosfamide: — The AI Regimen for Sarcoma
If your chart says 'AI regimen', it means treatment with doxorubicin and ifosfamide — two chemotherapy drugs given together for soft tissue sarcoma. This regimen is intensive, almost always requires a hospital stay, and the name alone leaves many questions unanswered.
- Two drugs, not one — AI stands for Adriamycin (doxorubicin) and Ifosfamide — two chemotherapy drugs given in the same course of treatment.
- Usually an inpatient stay — Ifosfamide is given as a continuous infusion over several days, which means most people are admitted to hospital for each cycle.
- A third medicine protects the bladder — Mesna is given alongside ifosfamide at every cycle. It is not chemotherapy — it prevents bladder damage from ifosfamide.
- Planned in cycles — Treatment is given in repeated courses separated by rest periods, with blood tests and review before each cycle starts.
Medically reviewed by Dr. Naresh Gundu, Medical Oncologist, MBBS (Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar) · DNB Internal Medicine (Sir Gangaram Hospital, New Delhi) · DM Medical Oncology (AIIMS) · Last reviewed September 2026
The AI regimen combines doxorubicin (also called Adriamycin) and ifosfamide, two chemotherapy drugs used for soft tissue sarcoma. Because ifosfamide is given as a continuous intravenous infusion over several days, this regimen is almost always given during a hospital admission, not as a day-care visit.
What are doxorubicin and ifosfamide, and why are they given together?
Doxorubicin is an anthracycline chemotherapy drug, sometimes referred to by its older brand name Adriamycin. It interferes with the way cancer cells copy their DNA, which prevents them from dividing. Ifosfamide is an alkylating agent that damages cancer cell DNA at a different point in the replication cycle.
Using both drugs together aims to attack sarcoma cells through more than one mechanism at the same time.
A third medicine, mesna, is given alongside ifosfamide at every cycle. Mesna is not chemotherapy — it protects the lining of the bladder from a toxic breakdown product that ifosfamide produces as it is processed by the body.
What do the terms on your paperwork mean?
- AI regimen
- The combination of doxorubicin and ifosfamide used to treat certain soft tissue sarcomas. AI comes from Adriamycin (doxorubicin) and Ifosfamide.
- Doxorubicin (Adriamycin)
- An anthracycline chemotherapy drug that interferes with DNA replication in cancer cells. Given intravenously.
- Ifosfamide
- An alkylating chemotherapy agent given as a continuous intravenous infusion over several days, which is why hospital admission is needed.
- Mesna
- A protective medicine given at every ifosfamide cycle. It is not chemotherapy — it prevents bladder damage from ifosfamide's toxic breakdown product.
- Cycle
- One complete course of treatment followed by a rest period. The number of cycles and the interval between them is decided individually by your oncologist.
Who should not receive doxorubicin and ifosfamide
Doxorubicin and ifosfamide are not appropriate for everyone with sarcoma. Several conditions make one or both drugs unsafe.
This regimen is generally not used in people who have:
- Significantly reduced heart function — doxorubicin is directly toxic to the heart muscle, and pre-existing weakness increases the risk of serious cardiac damage
- Severely impaired kidney function — ifosfamide is cleared through the kidneys and accumulates to harmful levels when they are not working adequately
- Pre-existing ifosfamide encephalopathy or significant neurological impairment
- Active severe infection, as the regimen substantially suppresses the immune system
- Pregnancy — both drugs carry significant risks to a developing fetus
- Severely reduced bone marrow reserve that cannot safely withstand intensive suppression
Eligibility is decided by an oncologist on each individual case, taking into account the person's full medical history, organ function, and the specific sarcoma being treated.
Why does the AI regimen usually need a hospital admission?
Ifosfamide is given as a continuous intravenous infusion over several days, not as a short injection that can be completed in a few hours. That alone makes day-care delivery impractical for most people.
During the admission your team monitors for ifosfamide encephalopathy — a neurological side effect that can cause confusion or unusual drowsiness — and for rapid changes in blood counts. Both are manageable when caught early.
Continuous intravenous hydration is also given alongside the ifosfamide to protect the kidneys and support the action of mesna. That hydration adds to the time needed.
What are the main effects of the AI regimen on the body?
How does doxorubicin affect the heart?
Doxorubicin can damage the heart muscle over time. The risk increases with the total amount received across all cycles, so there is a lifetime cumulative limit. Your heart function is checked with an echocardiogram or MUGA scan before and periodically during treatment. If function falls below a safe threshold, the dose may need to be adjusted or doxorubicin stopped. Tell your team about any breathlessness, palpitations, or ankle swelling.
What is ifosfamide encephalopathy, and what does it look like?
Ifosfamide encephalopathy occurs in a proportion of patients. It can cause confusion, unusual sleepiness, agitation, or difficulty speaking — typically during or shortly after the infusion. In most cases symptoms resolve when the drug is stopped and treatment is given. Your nursing team will check your alertness and orientation regularly during the infusion, which is one reason continuous observation matters.
What happens to blood counts?
Both drugs reduce the bone marrow's production of white blood cells, red blood cells and platelets. The lowest point — the nadir — occurs in the days to weeks after each cycle, before counts recover. Your team will schedule blood tests to monitor this. Low white cells increase infection risk, low red cells cause fatigue and breathlessness, and low platelets increase bleeding risk.
Will I lose my hair?
Doxorubicin causes hair loss in most people who receive it. Loss usually begins within the first few weeks and can include scalp hair, eyebrows and body hair. Hair regrows after treatment ends, though texture and thickness sometimes change temporarily. A cold cap reduces loss with some chemotherapy drugs but is generally less effective with doxorubicin — ask your team whether it is available at your centre.
What are the risks to the kidneys and bladder?
Ifosfamide produces a breakdown product that is toxic to the bladder lining. Mesna, given at the same time, neutralises it. Ifosfamide can also affect kidney tubule function over repeated cycles, so kidney blood tests are checked before each course. Tell your team immediately if you see blood in your urine during or after treatment.
How is nausea managed during the admission?
Nausea and vomiting are common with both drugs. Anti-nausea medicines are given before and during chemotherapy and continued as tablets after the infusion ends. Most people find nausea manageable with these medicines, though appetite may remain poor for several days after each cycle. Mouth soreness can also occur and tends to peak in the first week after treatment. Your ward team will advise on mouth care.
Explore 82 more How Chemotherapy Is Given: Regimens, Cycles & Infusion Days topics
Chemotherapy Regimens by Name
- 7+3 and Induction Regimens for Acute Leukaemia
- ABVD Regimen for Hodgkin Lymphoma
- AC and EC Regimens
- AC-T Regimen for Breast Cancer
- BEP Regimen for Testicular and Germ Cell Cancer
- CAPOX and XELOX Regimens
- CHOP Without Rituximab
- Carboplatin-Paclitaxel Regimen
- Cervical Cancer Chemotherapy and Chemoradiation Regimens
- Chemotherapy Regimens: What the Acronyms Mean
- Cisplatin-Pemetrexed and Platinum-Pemetrexed
- Comparing Two Regimens: How the Choice Is Made
- DCF and FLOT Regimens for Stomach Cancer
- Doxorubicin-Ifosfamide and Sarcoma Regimens
- EP and Carboplatin-Etoposide for Small Cell Lung Cancer
- FEC and CMF Regimens
- FOLFIRI Regimen
- FOLFIRINOX and Modified FOLFIRINOX
- FOLFOX Regimen for Colorectal Cancer
- GemCis and MVAC for Bladder Cancer
- Gemcitabine-Nab-Paclitaxel for Pancreatic Cancer
- R-CHOP Regimen for Lymphoma
- Salvage Lymphoma Regimens: ICE, DHAP and ESHAP
- TC Regimen (Docetaxel and Cyclophosphamide)
- TPF and Cisplatin Regimens for Head and Neck Cancer
- VRd, VCd and Myeloma Regimens
- Weekly Cisplatin With Radiation (Chemoradiation)
- Which Regimen Is Used for Which Cancer?
Cycle Delays, Dose Reductions & Changes
- Does a Delay Mean the Cancer Is Growing?
- Does a Reduced Dose Still Work?
- Growth Factor Support to Keep the Schedule
- How Many Delays Are Too Many?
- Infection Delaying a Cycle
- My Counts Were Too Low and the Cycle Was Postponed
- Organ Function Problems Delaying a Cycle
- Stopping Early: What Happens If You Do Not Complete the Course?
- Transfusion During Chemotherapy
- What If I Cannot Tolerate the Treatment?
- What Is a Dose Reduction and Why Was Mine Reduced?
- What to Ask If Your Plan Changes
- Why Chemotherapy Gets Delayed or Reduced
- Why Was My Regimen Switched?
HUB — Chemotherapy Regimens
HUB — Cycles, Schedules and What Happens on Infusion Day
How Chemotherapy Is Given
- Can Chemotherapy Be Given at Home?
- Can Chemotherapy Be Given at a Local Hospital?
- Continuous Infusion Chemotherapy and Portable Pumps
- Day Care vs Admission for Chemotherapy
- How Is Chemotherapy Given? All the Routes Explained
- How Long Does Each Chemotherapy Session Take?
- Intra-Arterial and Regional Chemotherapy
- Intraperitoneal Chemotherapy
- Intrathecal Chemotherapy: Into the Spinal Fluid
- Intravenous Chemotherapy: What the Drip Involves
- Intravesical Chemotherapy for the Bladder
- Is Oral Chemotherapy Weaker Than Injections?
- Oral Chemotherapy: Tablets Instead of a Drip
- Subcutaneous and Intramuscular Chemotherapy
- Topical Chemotherapy Creams
- What Safety Checks Happen Before Each Dose?
- Who Actually Gives Your Chemotherapy?
- Why Does the Route Sometimes Change During Treatment?
Regimens, Cycles & Schedules
- A Printable Chemotherapy Cycle Calendar
- Adding or Removing Cycles Mid-Course
- Blood Tests Before Every Cycle: What They Check
- Day 1, Day 8, Day 15: What the Day Numbers Mean
- Does Delaying a Cycle Reduce the Benefit?
- How Many Cycles Before the First Assessment?
- How the Dose Is Calculated for You
- Keeping a Chemotherapy Symptom Diary
- Planning Your Life Around Chemotherapy Cycles
- Rescheduling or Missing a Chemotherapy Appointment
- Weekly, Two-Weekly and Three-Weekly Schedules
- What Happens Between Cycles?
- What Happens at the Last Cycle?
- What Is Dose Intensity?
- What Is a Chemotherapy Cycle?
- What Is the Nadir and Why Does It Matter?
- Which Days of the Cycle Will I Feel Worst?
- Why Was My Cycle Postponed?
The Infusion Day
Your First Cycle
All How Chemotherapy Is Given: Regimens, Cycles & Infusion Days →
Frequently asked questions
How many cycles of the AI regimen are typically given?
There is no single answer — the number depends on your sarcoma type, how your disease responds, and how well your body tolerates the treatment. Most planned courses involve several cycles, but your oncologist will review imaging and blood results before each one and may revise the plan in either direction. Think of the cycle count as a working plan rather than a fixed commitment.
Can the AI regimen ever be given as a day-care infusion?
Rarely, and only in specific circumstances. Ifosfamide requires continuous infusion over several days with concurrent hydration, mesna, and monitoring for encephalopathy — a combination that makes full outpatient delivery difficult. Some centres use an adapted schedule that shortens the admission, but the monitoring requirements remain. Your oncologist will explain exactly what is planned for your situation.
What sarcomas is the AI regimen used for?
The AI regimen is used for soft tissue sarcomas. NCCN guidelines list it among regimens for various histological subtypes in both locally advanced and metastatic settings. It is not used for all sarcoma types — gastrointestinal stromal tumours, for example, are treated with targeted agents rather than conventional chemotherapy. Your oncologist will tell you whether this regimen fits your specific diagnosis.
What happens between hospital cycles?
You go home and daily activity gradually returns as your body recovers. The period of lowest blood counts — and highest infection risk — typically falls in the middle of each rest period. Blood tests are checked at an outpatient appointment around that time. If you develop a fever, feel suddenly unwell, or notice unexpected bleeding, contact your team or go to the emergency department without waiting.
How long is each hospital admission?
Most admissions last several days, depending on the ifosfamide schedule being used and how you respond. Some people need a longer stay if complications such as encephalopathy develop. The discharge decision is made on your clinical state rather than a fixed timetable. It is worth planning for some flexibility when arranging support at home.
What should I do if I get a fever after going home?
Contact your oncology team or go to the nearest emergency department immediately, and tell them you have recently had chemotherapy. A fever after this regimen is treated as a potential infection emergency, because bone marrow suppression means your body cannot fight infection normally. Do not take paracetamol and wait for it to settle. This applies for the weeks following each cycle, not only the first day or two after discharge.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.